Clinical Trials Browser

Phase 1 × Melanoma × Antibodies, Monoclonal × Clear all

NCT00356460 2014-03-19

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Phase 1 Completed

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma